期刊文献+

西藏自治区尼玛县一起导致3例死亡病例的水痘暴发疫情分析 被引量:4

An outbreak of varicella with three deaths in a remote village in Nima, Tibet
原文传递
导出
摘要 目的查明此次水痘疫情暴发的传染来源、传播途径和感染危险因素,为有效防控疫情提供科学依据。方法本次暴发调查的病例定义为:2010年11月7日以来,尼玛县吉瓦乡四村当贡自然村的村民中,出现发热(腋下温度≥37.3℃或自述发热者)伴有皮疹者。应用调查问卷搜集病例信息,主要内容包括基本信息(年龄、性别、住址)、发病时间、临床症状、就诊情况、疾病史和疫苗接种史等。采用酶联免疫吸附法(ELISA)检测3份健康者血清和8份现症病例血清水痘IgM抗体。结果此次疫情共发现15例病例,罹患率为20.5%,其中成人发病10例,罹患率为17.9%。死亡病例3例,病死率为20.O%,均为成人病例且出现呼吸困难等并发症。3例死亡病例均有10年以上结核病史,其他病例无相关疾病史,所有病例均无水痘疫苗接种史。3份健康者血清水痘IgM抗体均为阴性,8份现症病例血清中7份为阳性。结论易感性积累、水痘疫苗覆盖率低可能是此次疫情暴发的原因,而结核病导致的机体免疫力低下、严重并发症以及未及时有效治疗可能是导致成年病例死亡的主要原因。 Objective To indentify the source of the outbreak, mode of transmission and risk factors for outbreak of varieella. Methods A probable case was one with fever and rash since November 7 in 2010. The cases were investigated on demographic information, dates of onset, clinical symptoms, history of disease and varicella vaccination. Enzyme-linked immunosorbent assay was implied to test the IgM antibody of the serum of three healthy people and eight new cases. Results We found 15 cases, and the attack rate was 20. 5%. 10 of them were adult cases, and the attack rate was 17.9%. There were 3 dealths, and they were all adult patients with the serious complications. The three dealths had the history of tuberculosis, but not in the others. All cases had no history of varicella vaccination. The IgM antibody of the serum of 3 healthy people were negative, and 7 of the 8 eight new cases were positive. Conclusion The accumulation of susceptibility, low level of coverage rate of varicella vaccination might be the reasons for the outbreak. Hypoimmunity caused by tuberculosis, serious complications and having no effective treatment should be the reasons for dealth in adult cases.
出处 《国际病毒学杂志》 2011年第5期146-149,共4页 International Journal of Virology
关键词 水痘 暴发 流行病学 现场调查 Varicella Outbreak Epidemiology Field investigation
  • 相关文献

参考文献6

二级参考文献51

  • 1王官清,井上直樹,野沢直樹.水痘-带状疱疹病毒基因启动子分析[J].中华微生物学和免疫学杂志,2007,27(5):400-404. 被引量:5
  • 2周作卿,曹建海,潘昌珊.温州市龙湾区某小学水痘暴发调查[J].海峡预防医学杂志,2007,13(3):74-74. 被引量:1
  • 3Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis, 1996,174 Suppl 3 : S310-313.
  • 4Gnann JW. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis, 2002, 186 suppl 1:S91-98.
  • 5Durdu M, Baba M, Se? kin D. The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesion. J Am Acad Dermatol, 2008, 59 (6) : 958-964.
  • 6Nikkels AF, Pierard GE. The Tzanck smear: Heading the fight way! J Am Acad Dermatol, 2009, 61(1) : 152-153.
  • 7Schmutzhard J, Riedel HM, Wirgart BZ, et al. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicellazoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol, 2004, 29 (2) : 120-126.
  • 8Breuer J, Sehmid DS, Gershon AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaeeinees and to screen for susceptibility to varieella. J Infect Dis, 2008, 197 suppl. 2: S147-151.
  • 9Maple PAC, Gray J, Brown K, et al. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. J Virol Methods, 2009, 157 ( 1 ) : 90- 92.
  • 10Sauerbrei A, Wutzler P. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen. Clin Lab, 2009, 55 (1-2) : 1-7.

共引文献46

同被引文献21

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部